Arcutis Biotherapeutics, Inc.ARQTNASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
22.32%
↓ 65% below average
Average (30q)
64.28%
Historical baseline
Range
High:736.59%
Low:-69.45%
Volatility
1253.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 22.32% |
| Q2 2025 | 29.81% |
| Q1 2025 | -11.54% |
| Q4 2024 | 64.21% |
| Q3 2024 | 43.29% |
| Q2 2024 | -40.85% |
| Q1 2024 | 310.58% |
| Q4 2023 | -69.45% |
| Q3 2023 | 736.59% |
| Q2 2023 | 120.92% |
| Q1 2023 | -19.31% |
| Q4 2022 | 442.98% |
| Q3 2022 | 294.87% |
| Q2 2022 | -2.18% |
| Q1 2022 | -8.53% |
| Q4 2021 | -9.90% |
| Q3 2021 | -5.49% |
| Q2 2021 | -2.25% |
| Q1 2021 | -7.23% |
| Q4 2020 | 0.00% |
| Q3 2020 | 100.00% |
| Q2 2020 | 12.31% |
| Q1 2020 | -8.33% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |